Zdrowie i gospodarka · 14/08/2001

FDA Submits Information Collection for Review Under Paperwork Reduction Act

The Food and Drug Administration (FDA) has submitted a collection of information for review by the Office of Management and Budget (OMB) as part of the Paperwork Reduction Act of 1995, focusing on physician and patient attitudes toward Direct-to-Consumer (DTC) promotion drugs, and is seeking public comment on the proposed assessment.